October 2026

Veregen

sinecatechins

Ani Pharmaceuticals Inc

Ointment (topical) · NDA 021902

Last listed protection ended
October 2, 2026

The FDA listed 2 patents for Veregen, and this is the day the last one ended. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Ended
    Patent 9,770,406
    Claims the drug product and a use (U-172)
  2. Ended
    Patent 7,858,662
    Claims the drug product and a use (U-172)